Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.857515
Abstract: Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under investigation. This study… read more here.
Keywords: germline; tumour board; molecular tumour; model ... See more keywords
Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.984021
Abstract: Background The increasing amount of molecular data and knowledge about genomic alterations from next-generation sequencing processes together allow for a greater understanding of individual patients, thereby advancing precision medicine. Molecular tumour boards feature multidisciplinary teams… read more here.
Keywords: system; molecular tumour; tumour boards; design ... See more keywords